AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 76 min read$CTEV

Claritev Corporation Reports Second Quarter 2026 Results

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202

Original reporting
SEC EDGAR 8-K
Published Aug 7, 2026, 10:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 10:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CTEV
Bullish
medium confidence
Mentioned
$CTEV
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CTEVBullishMed
01

Why it matters

Traders can update models around the updated revenue, Adjusted EBITDA, and free cash flow ranges, and reassess near-term expectations ahead of the scheduled earnings call.

02

Market read

Q2 results show YoY revenue growth and improved operating cash flow and free cash flow, alongside updated FY 2026 guidance ranges.

03

What to watch

Unrestricted cash is only $14.4M at quarter end, and free cash flow guidance remains relatively tight ($5M-$15M), so liquidity and conversion risk may matter more than headline revenue growth.

Relevance 7/10Novelty 8/10Timing: pre-market today, Aug 7, 2026 8:00 a.m. ET conference call

Background

This is an SEC Form 8-K (Item 2.02) with an attached earnings press release covering Q2 2026 results and updated FY 2026 guidance.

Company-level read

Ticker impact

$CTEVBullishMedium confidence
Context

Claritev reported Q2 2026 results and updated full-year 2026 guidance, including revenue $1.00B-$1.02B and Adjusted EBITDA $610M-$620M.

Expected impact

Moderate upside bias if investors view the updated revenue and EBITDA range as credible and FCF trajectory improving.

Evidence & confidence

Q2 shows year-over-year revenue growth and higher operating cash flow and free cash flow, and management raised/updated full-year ranges; however, the release does not include consensus comparisons or a clear surprise magnitude.

Market effects

Sector

Healthcare data and insights peers may see read-through on demand strength and AI-driven execution narratives, but impact is likely company-specific.

Regional

Limited, as the disclosure is issuer-specific with no broader regional macro signal.

Global

Low, since the guidance and results are not tied to global regulatory or cross-border events.

Counterpoint

What could challenge this read

Despite revenue growth, the company still reported a large net loss, and Adjusted EBITDA margin declined versus Q2 2025, which could temper enthusiasm.

Key entities

  • issuer
    Claritev Corporation

    Technology, data, and insights company focused on healthcare affordability, transparency, and fairness.

  • executive
    Travis Dalton

    Chairman, CEO, and President, quoted on strategy execution and bookings strength.

  • executive
    Doug Garis

    CFO, quoted on revenue and Adjusted EBITDA performance and client success focus.

Read at source← All news

Related articles

AUG 9
$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

yahoo.com5 min
OCT 17
$TSMMed

TSMC vs. ASML: Which AI Expansion Demands More Cash?

TSMC (NYSE:TSM) reported Q3 revenue of NT$1.494 trillion with NT$443.21 billion in capital expenditure, while ASML (NASDAQ:ASML) reported €11.662 billion in sales with €447.2 million in spending. TSMC's higher capital intensity contrasts with ASML's lower direct investment, reflecting their different business models. Both companies are key players in AI infrastructure.

finance.yahoo.com3 min
OCT 17
$PLTRHighAI 8/10

Palantir (PLTR) stock forecast: Wall Street see 11% upside after 7% selloff

Palantir (PLTR) shares fell 7.22% to $186.03 on October 16, but analysts see 11% upside with a $206.43 average target. Q2 revenue surged 93% to $1.94B, driven by US commercial growth. Goldman Sachs, Baird, and Mizuho set targets at $230, $250, and $245, respectively, citing AI demand. Valuation concerns remain due to high P/E and revenue multiples.

beinsure.com3 min
OCT 17
$HDBMed

HDFC Bank Q2 Profit Meets Estimates; Margins Slip

HDFC Bank reported a Q2 profit of 195.1 billion rupees, matching estimates. Net interest income rose 9.7%, but margins slipped to 3.16%. Loans and deposits grew 16.3% and 18.8% respectively. New CEO Anup Bagchi will focus on governance and investor trust. Analysts note margin pressure and weaker earnings growth.

briefs.co2 min
OCT 17
$HDBMed

Q2 results 2026 race: HDFC vs ICICI Bank vs Axis Bank vs Yes Bank vs IDBI - Which bank won in PAT, NII, asset quality?

HDFC Bank, ICICI Bank, Axis Bank, Yes Bank, and IDBI Bank reported Q2FY27 results. ICICI, Axis, and Yes saw double-digit net profit growth, while HDFC had single-digit growth and IDBI a 39% decline. HDFC's profit was impacted by a 67% drop in treasury trading gains. ICICI's profit rose 20.1% with strong loan growth and lower provisions. Axis's profit jumped 38% due to lower provisions and improving asset quality. Yes Bank's profit surged 65% with 22.7% NII growth.

tradingview.com2 min